Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HEPATOCELLULAR CARCINOMA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
| Associated Genes | EXOSOMES, LRP1, MTOR, NF-KB, RAB7A, SLC7A11, TGF-BETA |
| KG Connections | 201 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
graph TD
HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"] -->|"associated"| METASTASIS["METASTASIS"]
style METASTASIS fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"] -->|"activates"| NF_KB["NF-KB"]
style NF_KB fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"] -->|"activates"| AKT["AKT"]
style AKT fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"] -->|"expressed in"| T_CELLS["T CELLS"]
style T_CELLS fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"] -->|"regulates"| OXIDATIVE_STRESS["OXIDATIVE STRESS"]
style OXIDATIVE_STRESS fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"] -->|"regulates"| INFLAMMATION["INFLAMMATION"]
style INFLAMMATION fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"] -->|"regulates"| TGF_BETA["TGF-BETA"]
style TGF_BETA fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
CELL_PROLIFERATION["CELL PROLIFERATION"] -->|"activates"| HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"]
style CELL_PROLIFERATION fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
AUTOPHAGY["AUTOPHAGY"] -.->|"inhibits"| HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"]
style AUTOPHAGY fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
METASTASIS_1["METASTASIS"] -->|"activates"| HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"]
style METASTASIS_1 fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
TGF_BETA_2["TGF-BETA"] -->|"associated"| HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"]
style TGF_BETA_2 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
NF_KB_3["NF-KB"] -.->|"inhibits"| HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"]
style NF_KB_3 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
style HEPATOCELLULAR_CARCINOMA fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| Als | therapeutic_target | disease | 1.00 |
| Carcinoma | associated_with | disease | 1.00 |
| Ferroptosis | activates | pathway | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| Carcinoma | activates | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Cancer | causes | disease | 1.00 |
| Carcinoma | therapeutic_target | disease | 1.00 |
| Liver Cancer | associated_with | disease | 0.95 |
| Carcinoma | causes | disease | 0.95 |
| Genomic Characterization | associated_with | process | 0.95 |
| Liver Cancer | therapeutic_target | disease | 0.95 |
| Hepatitis | associated_with | disease | 0.95 |
| Multimodal Tumor Thermal Therapy | therapeutic_target | process | 0.95 |
| Integrative Analysis | associated_with | process | 0.90 |
| Cancer Genome | biomarker_for | biomarker | 0.90 |
| Mtor | activates | pathway | 0.90 |
| Metastasis | activates | pathway | 0.90 |
| Pi3K/Akt | activates | pathway | 0.90 |
| Angiogenesis | involved_in | process | 0.85 |
| Inflammation | activates | disease | 0.85 |
| Inflammation | therapeutic_target | disease | 0.85 |
| Glycolysis | activates | pathway | 0.80 |
| Lipid Metabolism | therapeutic_target | pathway | 0.80 |
| Autophagy | associated_with | pathway | 0.80 |
| Apoptosis | activates | pathway | 0.80 |
| Er Stress | activates | pathway | 0.80 |
| Als | inhibits | disease | 0.75 |
| Als | causes | disease | 0.75 |
| Nafld | therapeutic_target | disease | 0.75 |
| Fatty Liver | therapeutic_target | disease | 0.75 |
| Carcinoma | inhibits | disease | 0.75 |
| Cancer | inhibits | disease | 0.75 |
| Hepatitis | activates | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Epigenetic | treats | pathway | 0.70 |
| Metastasis | inhibits | pathway | 0.70 |
| Mtor | treats | pathway | 0.70 |
| Oxidative Stress | activates | pathway | 0.70 |
| Autophagy | therapeutic_target | pathway | 0.70 |
| Lipid Metabolism | inhibits | pathway | 0.70 |
| Drug Resistance | therapeutic_target | pathway | 0.70 |
| Apoptosis | inhibits | pathway | 0.70 |
| Glycolysis | inhibits | pathway | 0.70 |
| Apoptosis | therapeutic_target | pathway | 0.70 |
| Tgf-Β | therapeutic_target | pathway | 0.70 |
| Nf-Κb | therapeutic_target | pathway | 0.70 |
| Cholesterol | therapeutic_target | pathway | 0.70 |
| Wnt | therapeutic_target | pathway | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Carcinoma | associated_with | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| AKT | activates | gene | 1.00 |
| GENES | activates | gene | 1.00 |
| FERROPTOSIS | activates | gene | 1.00 |
| PI3K | activates | gene | 1.00 |
| Tumor | associated_with | disease | 1.00 |
| CANCER | activates | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| Carcinoma | activates | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| Carcinoma | therapeutic_target | disease | 1.00 |
| CANCER | causes | gene | 1.00 |
| TMX2 | associated_with | gene | 0.95 |
| Cx3Cr1+Gpr56+ T Cells | biomarker_for | cell_type | 0.95 |
| Lactate | promotes | compound | 0.95 |
| Britannin | inhibits | compound | 0.95 |
| STAT3 | activates | gene | 0.95 |
| STAT3 | therapeutic_target | gene | 0.95 |
| P62 | activates | gene | 0.95 |
| NUPR1 | therapeutic_target | gene | 0.95 |
| GPC3 | biomarker_for | biomarker | 0.95 |
| AFP | biomarker_for | biomarker | 0.95 |
| Nash | causes | disease | 0.95 |
| PTEN | activates | gene | 0.95 |
| NRF2 | activates | gene | 0.95 |
| Nafld | contributes_to | disease | 0.95 |
| PI3K/AKT/mTOR Signaling | regulates | pathway | 0.95 |
| KEAP1 | activates | gene | 0.95 |
| INFLAMMATION | activates | gene | 0.95 |
| UBIQUITIN | activates | gene | 0.95 |
| DCP | biomarker_for | biomarker | 0.95 |
| CANCER | therapeutic_target | gene | 0.95 |
| Catenibacterium mitsuokai | promotes | organism | 0.95 |
| Lactate | causes | compound | 0.95 |
| Cancer Genome Atlas Research Network | involved_in | process | 0.95 |
| Central Nervous System | modulates | process | 0.95 |
| Peripheral Nervous System | modulates | process | 0.95 |
| Genomic Alterations | associated_with | mechanism | 0.95 |
| FDX1 | downregulates | gene | 0.95 |
| TGM2 | promotes | protein | 0.92 |
| HDAC2 | associated_with | gene | 0.92 |
| TMX2 | promotes | protein | 0.90 |
| Tumor Suppressor Genes | associated_with | mechanism | 0.90 |
| FDX1 | protects_against | gene | 0.90 |
| AKR1B10 | promotes | gene | 0.90 |
| mitophagy | therapeutic_target | process | 0.90 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity